| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis | Phase II | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | Frühe Phase I | rekrutiert |
| A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative | — | rekrutiert |
| A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With A | — | rekrutiert |
| A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disea | Phase I | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Re | Phase I | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children | Phase III | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanc | Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulce | Phase II | rekrutiert |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | Phase III | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia | — | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in P | Phase III | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 | Phase III | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients Wit | Phase III | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA | Phase III | rekrutiert |
| Analysis of Individual Activity at the Time of Aortic Rupture in Patients With Abdominal Aortic | — | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection | Phase I / Phase II | rekrutiert |
| Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool. | — | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting | — | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Ad | Phase III | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis | ohne Phasenangabe | rekrutiert |
| DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device | — | rekrutiert |
| Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligom | Phase II | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring S | Phase III | rekrutiert |
| Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to E | Phase III | rekrutiert |
| Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) | Phase III | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial | ohne Phasenangabe | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluating the Effectiveness of Typology-based Coaching on Patients' Therapy Management | ohne Phasenangabe | rekrutiert |
| FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early P | ohne Phasenangabe | rekrutiert |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FL | Phase II | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITIO | Phase II | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory | Phase I / Phase II | rekrutiert |
| HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediat | Phase I / Phase II | rekrutiert |
| HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pedi | Phase I / Phase II | rekrutiert |
| INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractor | Phase I / Phase II | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy | — | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Phase III | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genita | — | rekrutiert |
| Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy | ohne Phasenangabe | rekrutiert |
| Intraocular Lens Implant Registry Study | — | rekrutiert |
| Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patie | Phase II | rekrutiert |
| Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cel | Phase II | rekrutiert |
| Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at | — | rekrutiert |
| L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) | Phase II | rekrutiert |
| L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma | Phase II | rekrutiert |
| L19IL2/TNF in Patients With Basal Cell Carcinoma | Phase II | rekrutiert |
| Liquid Biopsy Under PSMA Radioligand Therapy | — | rekrutiert |
| Lumbar Drainage of Intraventricular Hemorrhage | ohne Phasenangabe | rekrutiert |
| Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Tri | ohne Phasenangabe | rekrutiert |
| Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Ge | Phase III | rekrutiert |
| Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-F | ohne Phasenangabe | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Neurovascular Product Surveillance Registry | — | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | Phase III | rekrutiert |
| Observational Study Protocol: LIVER-R | — | rekrutiert |
| Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Compl | Phase II | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally | Phase II | rekrutiert |
| Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line T | — | rekrutiert |
| Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial | Phase II / Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region | — | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody | Phase II | rekrutiert |
| Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Ad | ohne Phasenangabe | rekrutiert |
| Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma | Phase II | rekrutiert |
| REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT) | — | rekrutiert |
| ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast C | Phase III | rekrutiert |
| Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care A | Phase III | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer | — | rekrutiert |
| Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 | Phase III | rekrutiert |
| Register Schweres Asthma - German Asthma Net e.V. | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Registry for Vascular Trauma and Follow-up Examinations | — | rekrutiert |
| SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type | Phase II | rekrutiert |
| Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2- | Phase II | rekrutiert |
| Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor | Phase III | rekrutiert |
| Seroma of the Mammary Gland | ohne Phasenangabe | rekrutiert |
| Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participan | Phase III | rekrutiert |
| Stress Reduction Using Video Googles on Patients Undergoing Vascular Surgery | ohne Phasenangabe | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Rea | — | rekrutiert |
| Study on Sex-specific, Individualized Dose Calculation of Contrast Agent in CT Examinations | ohne Phasenangabe | rekrutiert |
| Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With A | — | rekrutiert |
| Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Co | Phase I / Phase II | rekrutiert |
| Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Pat | — | rekrutiert |
| Subcutaneous Suture Versus no Subcutaneous Suture for Abdominal Wound Closure | ohne Phasenangabe | rekrutiert |
| Terumo Aortic Global Endovascular Registry | — | rekrutiert |
| The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Tre | Phase IV | rekrutiert |
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation | Phase I / Phase II | rekrutiert |
| Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial | ohne Phasenangabe | rekrutiert |
| Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in A | — | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therap | Phase IV | rekrutiert |
| VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease | Phase IV | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |
| Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) | Phase III | rekrutiert |
| Vyxeos® With Clofarabine for Pediatric AML | Phase I | rekrutiert |
| Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly | — | rekrutiert |